bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s stock price was up 4.7% during mid-day trading on Monday . The company traded as high as $0.51 and last traded at $0.51. Approximately 800 shares changed hands during trading, a decline of 51% from the average daily volume of 1,633 shares. The stock had previously closed at $0.48.
bioAffinity Technologies Stock Performance
The business has a fifty day moving average of $0.55 and a 200-day moving average of $0.85.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Featured Stories
- Five stocks we like better than bioAffinity Technologies
- Energy and Oil Stocks Explained
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What Are the FAANG Stocks and Are They Good Investments?
- How Do Stock Buybacks Affect Shareholders?
- How to Read Stock Charts for Beginners
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
